Renal vascular lesions in childhood-onset lupus nephritis

被引:0
|
作者
Lin, Kyle Ying-kit [1 ]
Chan, Eugene Yu-hin [1 ,2 ]
Mak, Yuen-fun [4 ]
To, Ming-chun [4 ]
Wong, Sze-wa [1 ]
Lai, Fiona Fung-yee [1 ]
Ho, Tsz-wai [1 ]
Tong, Pak-chiu [1 ]
Lai, Wai-ming [1 ]
Yap, Desmond Yat-hin [5 ]
Ma, Alison Lap-tak [1 ,3 ]
机构
[1] Hong Kong Childrens Hosp, Paediat Nephrol Ctr, Hong Kong, Peoples R China
[2] Chinese Univ Hong Kong, Dept Paediat, Hong Kong, Peoples R China
[3] Univ Hong Kong, Dept Paediat & Adolescent Med, Hong Kong, Peoples R China
[4] Princess Margaret Hosp, Dept Pathol, Hong Kong, Peoples R China
[5] Univ Hong Kong, Queen Mary Hosp, Dept Med, Div Nephrol, Hong Kong, Peoples R China
关键词
Renal vascular lesions; Childhood-onset lupus nephritis; SLE; Systemic lupus erythematosus; Non-inflammatory necrotizing vasculopathy; Thrombotic microangiopathy; CLASSIFICATION; ERYTHEMATOSUS; VASCULOPATHY; PATHOLOGY; MANAGEMENT; CRITERIA; OUTCOMES;
D O I
10.1007/s00467-024-06498-z
中图分类号
R72 [儿科学];
学科分类号
100202 ;
摘要
BackgroundThis study aimed to determine the clinical significance of renal vascular lesions (RVLs) in childhood-onset lupus nephritis (cLN).MethodsWe retrospectively reviewed all children with biopsy-proven cLN between 2004-2020 to evaluate the prevalence of RVLs on kidney biopsy and its associated factors and long-term outcomes. The composite kidney outcome was defined as advanced chronic kidney disease (CKD) stage 3-5, kidney failure and death.Results107 biopsies from 84 Chinese patients were analysed. RVLs were observed in 19 patients (22.6%), including non-inflammatory necrotizing vasculopathy (NNV, n = 6), thrombotic microangiopathy (TMA, n = 4), arterial sclerosis (AS, n = 3), concurrent NNV with AS (n = 4), concurrent NNV with TMA (n = 1) and concurrent true renal vasculitis with AS (n = 1).The presence of RVLs was associated with lower estimated glomerular filtration rate (eGFR) (66.9 +/- 40.3 vs. 95.6 +/- 39.4 ml/min/1.73m2, p = 0.005), haemoglobin level (9.1 +/- 1.9 vs. 10.4 +/- 1.9 g/dL, p = 0.008) and platelet count (150.1 +/- 96.4 vs. 217.2 +/- 104.8 x 109/L, p = 0.01). LN classes and activity/chronicity indices were similar.Patients with RVLs had poorer composite kidney outcomes, though not reaching statistical significance (log-rank test, p = 0.06). The presence of NNV was associated with inferior survival free from composite kidney outcome (log-rank test, p = 0.0018), compared to other forms of RVLs and those without RVLs. Univariate analysis revealed NNV (HR 7.08, 95% CI 1.67-30.03) was predictive of composite kidney outcome.Results107 biopsies from 84 Chinese patients were analysed. RVLs were observed in 19 patients (22.6%), including non-inflammatory necrotizing vasculopathy (NNV, n = 6), thrombotic microangiopathy (TMA, n = 4), arterial sclerosis (AS, n = 3), concurrent NNV with AS (n = 4), concurrent NNV with TMA (n = 1) and concurrent true renal vasculitis with AS (n = 1).The presence of RVLs was associated with lower estimated glomerular filtration rate (eGFR) (66.9 +/- 40.3 vs. 95.6 +/- 39.4 ml/min/1.73m2, p = 0.005), haemoglobin level (9.1 +/- 1.9 vs. 10.4 +/- 1.9 g/dL, p = 0.008) and platelet count (150.1 +/- 96.4 vs. 217.2 +/- 104.8 x 109/L, p = 0.01). LN classes and activity/chronicity indices were similar.Patients with RVLs had poorer composite kidney outcomes, though not reaching statistical significance (log-rank test, p = 0.06). The presence of NNV was associated with inferior survival free from composite kidney outcome (log-rank test, p = 0.0018), compared to other forms of RVLs and those without RVLs. Univariate analysis revealed NNV (HR 7.08, 95% CI 1.67-30.03) was predictive of composite kidney outcome.Results107 biopsies from 84 Chinese patients were analysed. RVLs were observed in 19 patients (22.6%), including non-inflammatory necrotizing vasculopathy (NNV, n = 6), thrombotic microangiopathy (TMA, n = 4), arterial sclerosis (AS, n = 3), concurrent NNV with AS (n = 4), concurrent NNV with TMA (n = 1) and concurrent true renal vasculitis with AS (n = 1).The presence of RVLs was associated with lower estimated glomerular filtration rate (eGFR) (66.9 +/- 40.3 vs. 95.6 +/- 39.4 ml/min/1.73m2, p = 0.005), haemoglobin level (9.1 +/- 1.9 vs. 10.4 +/- 1.9 g/dL, p = 0.008) and platelet count (150.1 +/- 96.4 vs. 217.2 +/- 104.8 x 109/L, p = 0.01). LN classes and activity/chronicity indices were similar. Patients with RVLs had poorer composite kidney outcomes, though not reaching statistical significance (log-rank test, p = 0.06). The presence of NNV was associated with inferior survival free from composite kidney outcome (log-rank test, p = 0.0018), compared to other forms of RVLs and those without RVLs. Univariate analysis revealed NNV (HR 7.08, 95% CI 1.67-30.03) was predictive of composite kidney outcome.ConclusionRVLs are present in one-fifth of cLN patients and are associated with severe presentation. NNV is associated with worse long-term kidney outcome. Routine evaluation of RVLs is warranted and should be incorporated into future classification criteria.Graphical AbstractA higher resolution version of the Graphical abstract is available as Supplementary information
引用
收藏
页码:131 / 141
页数:11
相关论文
共 50 条
  • [41] Clinical Significance Of Renal Vascular Lesions (RVL) On Renal Biopsy In Lupus Nephritis
    Barber, Claire
    Herzenberg, Andrew
    Aghdassi, Ellie
    Su, Jiandong
    Lou, Wendy
    Qian, Gan
    Yip, Jonathan
    Nasr, Samih
    Thomas, David
    Wither, Joan
    Urowitz, Murray
    Gladman, Dafna
    Reich, Heather
    Fortin, Paul R.
    JOURNAL OF RHEUMATOLOGY, 2011, 38 (06) : 1181 - 1181
  • [42] Transition from lupus podocytopathy to diffuse proliferative lupus nephritis without proteinuria in childhood-onset systemic lupus erythematosus
    Fujinaga, Shuichiro
    Nishino, Tomohiko
    Mizutani, Akira
    Sakuraya, Koji
    Sakurai, Shunsuke
    CLINICAL NEPHROLOGY, 2017, 87 (04) : 217 - 219
  • [43] Association of systemic lupus erythematosus (SLE) genetic susceptibility loci with lupus nephritis in childhood-onset and adult-onset SLE
    Webber, Declan
    Cao, Jingjing
    Dominguez, Daniela
    Gladman, Dafna D.
    Levy, Deborah M.
    Ng, Lawrence
    Paterson, Andrew D.
    Touma, Zahi
    Urowitz, Murray B.
    Wither, Joan E.
    Silverman, Earl D.
    Hiraki, Linda T.
    RHEUMATOLOGY, 2020, 59 (01) : 90 - 98
  • [44] LUPUS HEADACHES IN THE CHILDHOOD-ONSET OF SYSTEMIC LUPUS ERYTHEMATOSUS
    Moradinejad, Mohammad Hassan
    Zamani, Gholamreza
    RHEUMATOLOGY, 2012, 51 : I22 - I22
  • [45] Renal Vascular Lesions in Lupus Nephritis: A Need for Further Characterization of Vasculopathy
    Nasri, Hamid
    Mubarak, Muhammed
    SAUDI JOURNAL OF KIDNEY DISEASES AND TRANSPLANTATION, 2015, 26 (03) : 604 - 607
  • [46] Use of EuroLupus Cyclophosphamide Dosing for the Treatment of Lupus Nephritis in Childhood-Onset Systemic Lupus Erythematosus in North America
    Cannon, Laura
    Wenderfer, Scott
    Lewandowski, Laura
    Cooper, Jennifer
    Goilav, Beatrice
    Knight, Andrea
    Hersh, Aimee
    Ardoin, Stacy
    Sadun, Rebecca
    ARTHRITIS & RHEUMATOLOGY, 2021, 73 : 1606 - 1609
  • [47] ANTIPHOSPHOLIPID ANTIBODIES AND VASCULAR RENAL LESIONS AS PROGNOSTIC FACTORS IN LUPUS NEPHRITIS
    Paglionico, A.
    Varriano, V.
    Petricca, L.
    Vischini, G.
    Di Mario, C.
    Gigante, M. R.
    Tanti, G.
    Costanzi, S.
    Grandaliano, G.
    Tolusso, B.
    Ferraccioli, G.
    Gremese, E.
    ANNALS OF THE RHEUMATIC DISEASES, 2020, 79 : 1051 - 1051
  • [48] Use of EuroLupus Cyclophosphamide Dosing for the Treatment of Lupus Nephritis in Childhood-onset Systemic Lupus Erythematosus in North America
    Cannon, Laura A.
    Wenderfer, Scott E.
    Lewandowski, Laura B.
    Cooper, Jennifer C.
    Goilav, Beatrice
    Knight, Andrea M.
    Hersh, Aimee O.
    Ardoin, Stacy P.
    Sadun, Rebecca E.
    JOURNAL OF RHEUMATOLOGY, 2022, 49 (06) : 607 - 614
  • [49] The value of 2019 EULAR/ACR classification criteria in predicting lupus nephritis in childhood-onset systemic lupus erythematosus
    Cetin, Nuran
    Acikalin, Mustafa Fuat
    Tufan, Asli Kavaz
    Kasifoglu, Nilgun
    KLINISCHE PADIATRIE, 2023, 235 (05): : 277 - 283
  • [50] Differences in rituximab use between pediatric rheumatologists and nephrologists for the treatment of refractory lupus nephritis and renal flare in childhood-onset SLE
    Gilbert, Mileka
    Goilav, Beatrice
    Hsu, Joyce J.
    Nietert, Paul J.
    Meidan, Esra
    Chua, Annabelle
    Ardoin, Stacy P.
    Wenderfer, Scott E.
    von Scheven, Emily
    Ruth, Natasha M.
    PEDIATRIC RHEUMATOLOGY, 2021, 19 (01)